Literature DB >> 18460971

European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe.

Timo Vesikari1, Pierre Van Damme, Carlo Giaquinto, Jim Gray, Jacek Mrukowicz, Ron Dagan, Alfredo Guarino, Hania Szajewska, Vytautas Usonis.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18460971     DOI： 10.1097/MPG.0b013e31816f7a10

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  13 in total

Review 1.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

2.  Results from a randomized clinical trial of coadministration of RotaTeq, a pentavalent rotavirus vaccine, and NeisVac-C, a meningococcal serogroup C conjugate vaccine.

Authors:  Timo Vesikari; Aino Karvonen; Ray Borrow; Nick Kitchin; Martine Baudin; Stéphane Thomas; Anne Fiquet
Journal:  Clin Vaccine Immunol       Date:  2011-03-09

3.  Rotavirus immunization: Global coverage and local barriers for implementation.

Authors:  Andrea Lo Vecchio; Ilaria Liguoro; Jorge Amil Dias; James A Berkley; Chris Boey; Mitchell B Cohen; Sylvia Cruchet; Eduardo Salazar-Lindo; Samir Podder; Bhupinder Sandhu; Philip M Sherman; Toshiaki Shimizu; Alfredo Guarino
Journal:  Vaccine       Date:  2017-02-16       Impact factor: 3.641

Review 4.  Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2010-06-18       Impact factor: 9.546

Review 5.  Rotavirus vaccine RIX4414 (Rotarix): a review of its use in the prevention of rotavirus gastroenteritis.

Authors:  Paul L McCormack; Susan J Keam
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

6.  Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial.

Authors:  Satoshi Iwata; Shuji Nakata; Susumu Ukae; Yoshitugu Koizumi; Yasuyuki Morita; Haruo Kuroki; Yoshiyuki Tanaka; Toshiyuki Shizuya; Florian Schödel; Michelle L Brown; Jody Lawrence
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

Review 7.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

8.  The impact of childhood acute rotavirus gastroenteritis on the parents' quality of life: prospective observational study in European primary care medical practices.

Authors:  Javier Diez Domingo; Marian Patrzalek; Luigi Cantarutti; Benoit Arnould; Juliette Meunier; Montse Soriano-Gabarro; Nadia Meyer; Jean-Yves Pirçon; Katsiaryna Holl
Journal:  BMC Pediatr       Date:  2012-05-31       Impact factor: 2.125

9.  Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in developed countries.

Authors:  Greg L Plosker
Journal:  Drugs R D       Date:  2012-12-01

Review 10.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-05       Impact factor: 4.558
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.